Difenoxin

This classification denotes an antidiarrheal agent with the molecular formula C28H28N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3ZZ5BJ9F2Q, chemically known as 4-piperidinecarboxylic acid, 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl- but generally known as difenoxin, which bears US NIH Compound Identifier 34328. European Medicines Agency schedules Difenoxin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07123MIG. The term DIFENOXIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules difenoxin in its Anatomical Therapeutic Chemical (ATC) Classification. DIFENOXIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule difenoxin under HS 29333300 and SITC 51574. As of Q4 2014, DIFENOXIN remains the US FDA Preferred Term for this commodity. Difenoxin bears US NLM identifiers UMLS ID C0057981 and NCI Concept Code C65381. SMILES: OC(=O)C1(CCN(CC1)CCC(C1CCCCC1)(C1CCCCC1)C#N)C1CCCCC1.